Studies presented at the American Diabetes Association's meeting in San Francisco took a deeper look at what the presence of fat does to overweight children. Researchers found that signs of trouble emerge early, with implications for the treatment of youths with type 1 diabetes, and those at risk of developing type 2 diabetes.
Childhood obesity is more than a “problem,” it’s an indicator that what’s gone wrong metabolically has set young people up for a host of health problems later on. What’s worse, once a child becomes overweight, it can be very hard to reverse either the weight gain or its effects.
Studies presented at Sunday morning’s session, “Fitness and Fatness in Youth With or At Risk of Diabetes,” revealed how much researchers are learning about the effects of excess weight in children and teenagers, right down to the cellular level.
The sessions reflected a larger message at the 74th Scientific Sessions of the American Diabetes Association, which conclude Tuesday in San Francisco, California: children are not “little adults.” Their bodies react differently to risk factors, and this reality must be taken into account when developing treatment for obesity and diabetes mellitus, both type 1 (T1DM) and type 2 (T2DM). Obesity’s rise, both in the United States and around the world, is especially problematic for T1DM youth, as they must take insulin which puts them at further risk of weight gain. Among the studies presented:
An audience member observed that that many of the results had implications for the emotionally charged issue of encouraging weight loss in younger girls; the commenter said data show girls who are overweight in their teens are more likely to skip insulin.
A sign of hope came from Curtis Harrod, MPH, of the University of Colorado, whose study examined the relationship between physical activity during pregnancy and infant birth weight and neonatal composition. Harrod found that there was little relationship between activity in the first two trimesters and neonatal composition, but that increased activity in the final trimester was associated with lower levels of neonatal adiposity. Thus, encouraging mothers who are at-risk of having overweight children to exercise more during pregnancy could have positive effects on the child at birth, and later in life.5
References
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More